| A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease MED Flowers, JF Apperley, K van Besien, A Elmaagacli, A Grigg, V Reddy, ... Blood, The Journal of the American Society of Hematology 112 (7), 2667-2674, 2008 | 407 | 2008 |
| Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid … AH Elmaagacli, NK Steckel, M Koldehoff, Y Hegerfeldt, R Trenschel, ... Blood, The Journal of the American Society of Hematology 118 (5), 1402-1412, 2011 | 372 | 2011 |
| Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after … DW Beelen, A Elmaagacli, KD Müller, H Hirche, UW Schaefer Blood, The Journal of the American Society of Hematology 93 (10), 3267-3275, 1999 | 324 | 1999 |
| Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose C Guglielmi, W Arcese, F Dazzi, R Brand, D Bunjes, LF Verdonck, ... Blood, The Journal of the American Society of Hematology 100 (2), 397-405, 2002 | 247 | 2002 |
| Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell … DW Beelen, HD Ottinger, S Ferencik, AH Elmaagacli, R Peceny, ... Blood 105 (6), 2594-2600, 2005 | 225 | 2005 |
| Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation M Ditschkowski, H Einsele, R Schwerdtfeger, D Bunjes, R Trenschel, ... Transplantation 75 (10), 1745-1747, 2003 | 225 | 2003 |
| Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched … HD Ottinger, S Ferencik, DW Beelen, M Lindemann, R Peceny, ... Blood 102 (3), 1131-1137, 2003 | 175 | 2003 |
| Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on … A Ruggeri, M Labopin, A Bacigalupo, B Afanasyev, JJ Cornelissen, ... Journal of hematology & oncology 11, 1-10, 2018 | 172 | 2018 |
| Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic … AH Elmaagacli, M Koldehoff, H Hindahl, NK Steckel, R Trenschel, ... Transplantation 81 (2), 247-254, 2006 | 165 | 2006 |
| Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT) B Hertenstein, L Hambach, A Bacigalupo, N Schmitz, S McCann, S Slavin, ... haematologica 90 (7), 969-975, 2005 | 165 | 2005 |
| Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis—results of a crossover … HT Greinix, K van Besien, AH Elmaagacli, U Hillen, A Grigg, R Knobler, ... Biology of Blood and Marrow Transplantation 17 (12), 1775-1782, 2011 | 155 | 2011 |
| Quantitative analysis of chimerism after allogeneic stem cell transplantation by real‐time polymerase chain reaction with single nucleotide polymorphisms, standard tandem … M Koldehoff, NK Steckel, M Hlinka, DW Beelen, AH Elmaagacli American journal of hematology 81 (10), 735-746, 2006 | 152 | 2006 |
| Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow … DW Beelen, U Graeven, AH Elmaagacli, N Niederle, O Kloke, B Opalka, ... | 140 | 1995 |
| The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after … AH Elmaagacli, DW Beelen, B Opalka, S Seeber, UW Schaefer Blood, The Journal of the American Society of Hematology 94 (2), 384-389, 1999 | 139 | 1999 |
| Sorafenib as maintenance therapy post allogeneic stem cell transplantation for FLT3-ITD positive AML: results from the randomized, double-blind, placebo-controlled multicentre … A Burchert, G Bug, J Finke, M Stelljes, C Rollig, R Wäsch, M Bornhäuser, ... Blood 132, 661, 2018 | 120 | 2018 |
| The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic … AH Elmaagacli, DW Beelen, B Opalka, S Seeber, UW Schaefer Annals of hematology 79, 424-431, 2000 | 107 | 2000 |
| Improved disease-free–survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first … AH Elmaagacli, S Basoglu, R Peceny, R Trenschel, H Ottinger, A Lollert, ... Blood, The Journal of the American Society of Hematology 99 (4), 1130-1135, 2002 | 104 | 2002 |
| Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood … AH Elmaagacli, R Peceny, N Steckel, R Trenschel, H Ottinger, ... Blood, The Journal of the American Society of Hematology 101 (2), 446-453, 2003 | 100 | 2003 |
| Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia M Koldehoff, NK Steckel, DW Beelen, AH Elmaagacli Clinical and experimental medicine 7, 47-55, 2007 | 98 | 2007 |
| Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a … DW Beelen, HD Ottinger, A Elmaagacli, B Scheulen, O Basu, B Kremens, ... Blood, The Journal of the American Society of Hematology 90 (12), 4725-4735, 1997 | 95 | 1997 |
